Aabo-Rosendal ApS: Financial statements 2019
CVR: 37086029
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Aabo-Rosendal ApS (CVR 37086029) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,893,541 and a net result of DKK 498,808 compared with DKK 1,811,787 the year before. That is a decrease of 49.9% compared with the year before. Equity in the 2019 report amounted to DKK 574,547. The solvency ratio was 55.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,893,541
- Profit/Loss
- DKK 498,808
- Equity
- DKK 574,547
- Total Assets
- DKK 1,042,351
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.9 mio. | 499 t. | 575 t. | 3 |
| 2018 | - | 3.8 mio. | 1.8 mio. | 1.9 mio. | 2 |
| 2017 | - | 2.8 mio. | 1.5 mio. | 1.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Aabo-Rosendal ApS has published its annual report for 2018. Gross profit came to DKK 3,781,039, and the net result was DKK 1,811,787.
About Aabo-Rosendal ApS
Aabo-Rosendal ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company has been dissolved on 13 June 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Neurokirurgisk Smerteklinik ApS. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK 2,784,347 and a net result of DKK 1,134,946 compared with DKK 2,254,841 the year before. Equity in the 2023 report amounted to DKK 1,227,501.